1. Academic Validation
  2. LDK378: a promising anaplastic lymphoma kinase (ALK) inhibitor

LDK378: a promising anaplastic lymphoma kinase (ALK) inhibitor

  • J Med Chem. 2013 Jul 25;56(14):5673-4. doi: 10.1021/jm401005u.
Jianyong Chen 1 Cheng Jiang Shaomeng Wang
Affiliations

Affiliation

  • 1 Department of Internal Medicine, University of Michigan Comprehensive Cancer Center, University of Michigan , Ann Arbor, Michigan 48109, United States.
Figures
Products